Gene · 1959
Papers3,476
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,476
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of silybin on triptorelin-induced bone metabolic abnormalities in prostate cancer revealed based on TMT-based proteomics. | PLoS One | 2026 | 41610125 | PubTator, text mining | PubMed |
| The Role of the Cysteamine Dioxygenase (ADO) Gene in Atopic Dermatitis. | Acta Derm Venereol | 2026 | 41601200 | PubTator, text mining | PubMed |
| Hereditary Polyneuropathies in the Era of Precision Medicine: Genetic Complexity and Emerging Strategies. | Genes (Basel) | 2026 | 41595476 | PubTator, text mining | PubMed |
| Epigenetic and Molecular Regulation of EGR2 Activates Quiescent HFSCs & Harness Hair regeneration. | Stem Cell Rev Rep | 2026 | 41557131 | PubTator, text mining | PubMed |
| Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. | Hemasphere | 2026 | 41551728 | PubTator, text mining | PubMed |
| Neuro-related gene signatures predict prognosis in diffuse large B-Cell lymphoma and uncover TRPV2-mediated tumor microenvironment regulation. | Ann Hematol | 2026 | 41549103 | PubTator, text mining | PubMed |
| Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. | Sci Rep | 2026 | 41535376 | PubTator, text mining | PubMed |
| Retraction: LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells. | PLoS One | 2026 | 41499454 | PubTator, text mining | PubMed |
| EGR Proteins Mediate Interferon-Independent Anti-HSV-1 Responses Through Viral and Host Targets. | Adv Sci (Weinh) | 2026 | 41486724 | PubTator, text mining | PubMed |
| Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study. | Clin Orthop Relat Res | 2026 | 40971882 | PubTator, text mining | PubMed |
| Exploration and validation of biomarkers for Alzheimer's disease based on GEO database. | IBRO Neurosci Rep | 2025 | 41601569 | PubTator, text mining | PubMed |
| Integrating zinc homeostasis network and immune landscape: a five-gene prognostic framework for precision oncology in lung adenocarcinoma. | Front Immunol | 2025 | 41583466 | PubTator, text mining | PubMed |
| Comprehensive Bioinformatics Analysis the circRNAs of Viral Infection Associated Pathway in HepG2 Expressing ORF3 of Genotype IV Swine Hepatitis E Virus. | Microorganisms | 2025 | 41471859 | PubTator, text mining | PubMed |
| Transcriptomic signatures in Gaucher disease subtypes: A systems biology perspective. | Mol Genet Metab Rep | 2025 | 41323100 | PubTator, text mining | PubMed |
| Characterising PMP22-Proximal Partners in a Schwann Cell Model of Charcot-Marie-Tooth Disease Type1A. | Biology (Basel) | 2025 | 41300342 | PubTator, text mining | PubMed |
| Disruption of Krox20-Notch1 signaling blocks meibomian gland development and homeostasis leading to dry eye disease. | Nat Commun | 2025 | 41276517 | PubTator, text mining | PubMed |
| A critical role of the Erk1/2 downstream targets c-Fos, Egr-1, and Egr-2 in PU.1-driven monocyte development. | J Leukoc Biol | 2025 | 41206684 | PubTator, text mining | PubMed |
| BET proteins mediate survival mechanisms in human schwannoma model cells challenged with trametinib but not brigatinib. | Oncogene | 2025 | 41206370 | PubTator, text mining | PubMed |
| Transcription factor EGR2 drives cataract formation through IGFBP3-mediated oxidative injury in lens epithelial cells. | Free Radic Biol Med | 2025 | 41093149 | PubTator, text mining | PubMed |
| Clinical Spectrum, Pathology, and Mechanisms of Anti-LGI4 Antibody-Positive Autoimmune Nodopathy. | Neurol Neuroimmunol Neuroinflamm | 2025 | 41092257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1959/papers?page=3